BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32748196)

  • 21. Dynamic changes of different phenotypic and genetic circulating tumor cells as a biomarker for evaluating the prognosis of RCC.
    Wang ZL; Zhang P; Li HC; Yang XJ; Zhang YP; Li ZL; Xue L; Xue YQ; Li HL; Chen Q; Chong T
    Cancer Biol Ther; 2019; 20(4):505-512. PubMed ID: 30359544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.
    Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R
    Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aneuploid CTC and CEC.
    Lin PP
    Diagnostics (Basel); 2018 Apr; 8(2):. PubMed ID: 29670052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of two detection systems for circulating tumor cells among patients with renal cell carcinoma.
    Bai M; Zou B; Wang Z; Li P; Wang H; Ou Y; Cui K; Bian J; Li S; Xu X
    Int Urol Nephrol; 2018 Oct; 50(10):1801-1809. PubMed ID: 30120680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection and clinical significance of circulating tumor cells in osteosarcoma using immunofluorescence combined with in situ hybridization].
    Zhang HQ; Li MH; Wang Z; Lan PH; Lu YJ; Chen GJ; Wang L
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):485-489. PubMed ID: 28728292
    [No Abstract]   [Full Text] [Related]  

  • 26. Application of a novel liquid biopsy in patients with hepatocellular carcinoma undergoing liver transplantation.
    Xue F; Shi S; Zhang Z; Xu C; Zheng J; Qin T; Qian Z; Zhao X; Tong Y; Xia L; Xia Q
    Oncol Lett; 2018 Apr; 15(4):5481-5488. PubMed ID: 29552189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma.
    Guan Y; Xu F; Tian J; Gao K; Wan Z; Wang Y; Gao M; Wang Z; Chong T
    BMC Cancer; 2021 Jul; 21(1):826. PubMed ID: 34271857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative Circulating Tumor Cells (CTCs), MCTCs, and CTC-White Blood Cells Detected by a Size-Based Platform Predict Prognosis in Renal Cell Carcinoma.
    Wang Z; Zhang P; Chong Y; Xue Y; Yang X; Li H; Wang L; Zhang Y; Chen Q; Li Z; Xue L; Li H; Chong T
    Dis Markers; 2021; 2021():9956142. PubMed ID: 34733376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
    Sun YF; Yang XR; Zhou J; Qiu SJ; Fan J; Xu Y
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1151-73. PubMed ID: 21681690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the prognostic role and biological characteristics of circulating tumor cell-associated white blood cell clusters in non-small cell lung cancer.
    Li Z; Fan L; Wu Y; Niu Y; Zhang X; Wang B; Yao Y; Chen C; Qi N; Wang DD; Lin PP; Tang D; Gao W
    J Thorac Dis; 2022 May; 14(5):1544-1555. PubMed ID: 35693614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model.
    Jiang J; Wang DD; Yang M; Chen D; Pang L; Guo S; Cai J; Wery JP; Li L; Li HQ; Lin PP
    Oncotarget; 2015 Jun; 6(17):15639-51. PubMed ID: 25909226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity.
    Yang X; Lv J; Zhou Z; Feng D; Zhou R; Yuan B; Wu Q; Yu H; Han J; Cao Q; Gu M; Li P; Yang H; Lu Q
    Front Oncol; 2021; 11():802188. PubMed ID: 35186716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of circulating tumor cells in patients with locally advanced head and neck squamous cell carcinoma.
    Liu K; Chen N; Wei J; Ma L; Yang S; Zhang X
    Oncol Rep; 2020 May; 43(5):1525-1535. PubMed ID: 32323844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer.
    Chen YY; Xu GB
    Med Oncol; 2014 Dec; 31(12):240. PubMed ID: 25361883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas.
    Li M; Gao F; Ren X; Dong G; Chen H; Lin AY; Wang DD; Liu M; Lin PP; Shen S; Jiang H; Yang C; Zhang X; Zhao X; Zhu Q; Li M; Cui Y; Lin S
    Cancer Sci; 2022 Oct; 113(10):3535-3546. PubMed ID: 35940591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization.
    Liu X; Zhang Z; Zhang B; Zheng Y; Zheng C; Liu B; Zheng S; Dong K; Dong R
    EBioMedicine; 2018 Sep; 35():244-250. PubMed ID: 30104180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of circulating tumor cells in patients with ampullary cancer.
    Sun B; Liu H; Wang S; Xiang J; Liu X
    J Cell Physiol; 2018 Jun; 233(6):5014-5022. PubMed ID: 29215725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aneuploid subtypes of circulating tumor cells and circulating tumor-derived endothelial cells predict the overall survival of advanced lung cancer.
    Zhang J; Hong Y; Wang L; Hu W; Tian G; Wu D; Wang Y; Dai L; Zhang Z; Yang Y; Fang J
    Front Oncol; 2023; 13():829054. PubMed ID: 37213309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Tumor Cells Correlate with Clinicopathological Features and Outcomes in Differentiated Thyroid Cancer.
    Qiu ZL; Wei WJ; Sun ZK; Shen CT; Song HJ; Zhang XY; Zhang GQ; Chen XY; Luo QY
    Cell Physiol Biochem; 2018; 48(2):718-730. PubMed ID: 30025398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.